← Leaderboards
Maurizio Del Poeta
Northport Va Medical Center
$23,092,023
Attributed
$23,678,656
Total exposure
20
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,678,656 · 18
VA$0 · 2
By mechanism
R01$21,462,216 · 7
R21$1,141,696 · 3
R41$579,393 · 2
P20$474,351 · 4
R13$21,000 · 2
IK6$0 · 1
Top collaborators
- Michael Virgil Airola1 shared
- Iwao Ojima1 shared
- Robert C. Rizzo1 shared
Others in their field
Top investigators on “Cryptococcus Neoformans”
- Arturo Casadevall · Johns Hopkins University$33,951,910
- Joseph Heitman · Duke University$33,924,189
- Hiten D Madhani · University Of California, San Francisco$24,815,163
- Tamara L Doering · Washington University$20,134,929
- Stuart M Levitz · Duke University$16,533,146
- Jennifer K. Lodge · Duke University$14,144,715
Research focus
Cryptococcus NeoformansInfectionCellsFungusMycosesLungPathogenesisBrainInsightVirulencePathway InteractionsLifeIn VitroLeadPathogenicitySphingolipidsImmunocompromised HostImmune ResponseCryptococcosisMouse ModelEnvironmentImmunityNovel Therapeutic InterventionCryptococcus Neoformans Infection
Grant awards (71)
Developing new antifungals against sterolglycosidases$782,178
R01 · FY2025 · AI · contact PI
New antifungals targeting the synthesis of fungal sphingolipids$752,843
R01 · FY2025 · AI · contact PI
Sphingosine kinase and cryptococcal granuloma$749,594
R01 · FY2025 · AI · contact PI
Lipid-mediated fungal pathogenesis$659,883
R01 · FY2025 · AI · contact PI
Role of host sphingolipids against fungal infections$0
I01 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
New antifungals targeting the synthesis of fungal sphingolipids$755,208
R01 · FY2024 · AI · contact PI
Lipid-mediated fungal pathogenesis$659,883
R01 · FY2024 · AI · contact PI
Targeting fungal ceramide synthases as new antifungals$300,000
R41 · FY2024 · AI · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
New antifungals targeting the synthesis of fungal sphingolipids$767,822
R01 · FY2023 · AI · contact PI
Lipid-mediated fungal pathogenesis$659,883
R01 · FY2023 · AI · contact PI
Role of host sphingolipids against fungal infections$0
I01 · FY2023 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
New antifungals targeting the synthesis of fungal sphingolipids$768,609
R01 · FY2022 · AI · contact PI
Lipid-mediated fungal pathogenesis$659,883
R01 · FY2022 · AI · contact PI
Sphingosine-1-phosphate and cryptococcosis$498,277
R01 · FY2022 · AI · contact PI
Role of host sphingolipids against fungal infections$0
I01 · FY2022 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
New antifungals targeting the synthesis of fungal sphingolipids$782,800
R01 · FY2021 · AI · contact PI
Lipid-mediated fungal pathogenesis$659,883
R01 · FY2021 · AI · contact PI
Sphingosine-1-phosphate and cryptococcosis$498,277
R01 · FY2021 · AI · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2021 · VA · contact PI
Role of host sphingolipids against fungal infections$0
I01 · FY2021 · VA · contact PI
New antifungals targeting the synthesis of fungal sphingolipids$590,457
R01 · FY2020 · AI · contact PI
Lipid-mediated fungal pathogenesis$581,924
R01 · FY2020 · AI · contact PI
Sphingosine-1-phosphate and cryptococcosis$498,277
R01 · FY2020 · AI · contact PI
Role of host sphingolipids against fungal infections$0
I01 · FY2020 · VA · contact PI
New antifungals targeting the synthesis of fungal sphingolipids$591,542
R01 · FY2019 · AI · contact PI
Lipid-mediated fungal pathogenesis$581,924
R01 · FY2019 · AI · contact PI
Sphingosine-1-phosphate and cryptococcosis$498,277
R01 · FY2019 · AI · contact PI
Role of host spingolipids against fungal infections$0
I01 · FY2019 · VA · contact PI
New antifungals targeting the synthesis of fungal sphingolipids$593,029
R01 · FY2018 · AI · contact PI
Lipid-mediated fungal pathogenesis$581,924
R01 · FY2018 · AI · contact PI
Sphingosine-1-phosphate and cryptococcosis$497,633
R01 · FY2018 · AI · contact PI
Targeting the sphingolipid pathway for the R&D of new antifungals$279,393
R41 · FY2018 · AI · contact PI
Role of host spingolipids against fungal infections$0
I01 · FY2018 · VA · contact PI
New antifungals targeting the synthesis of fungal sphingolipids$594,484
R01 · FY2017 · AI · contact PI
Lipid-mediated fungal pathogenesis$580,113
R01 · FY2017 · AI · contact PI
10th International Conference on Cryptococcus and Cryptococcosis$6,000
R13 · FY2017 · AI · contact PI
Role of host spingolipids against fungal infections$0
I01 · FY2017 · VA · contact PI
New antifungals targeting the synthesis of fungal sphingolipids$610,218
R01 · FY2016 · AI · contact PI
Lipid-mediated fungal pathogenesis$576,491
R01 · FY2016 · AI · contact PI
Role of host spingolipids against fungal infections$0
I01 · FY2016 · VA · contact PI
Identification of new compounds against fungal microbes$197,448
R21 · FY2014 · AI · contact PI
Sphingolipid-mediated fungal pathogenesis$290,208
R01 · FY2013 · AI · contact PI
Identification of new compounds against fungal microbes$227,143
R21 · FY2013 · AI · contact PI
Sphingolipid-mediated fungal pathogenesis$307,915
R01 · FY2012 · AI · contact PI
Role of phagocytosis in pathogenesis of Cryptococcus neorformans$192,089
R01 · FY2012 · AI · contact PI
Role of phagocytosis in pathogenesis of Cryptococcus neorformans$160,925
R01 · FY2012 · AI · contact PI
Role of phagocytosis in pathogenesis of Cryptococcus neorformans$341,589
R01 · FY2011 · AI · contact PI
Sphingolipid-mediated fungal pathogenesis$289,130
R01 · FY2011 · AI · contact PI
8th International Conference on Cryptococcus and Cryptococcosis$15,000
R13 · FY2011 · AI · contact PI
Role of phagocytosis in pathogenesis of Cryptococcus neorformans$339,580
R01 · FY2010 · AI · contact PI
Sphingolipid-mediated fungal pathogenesis$292,050
R01 · FY2010 · AI · contact PI
Role of phagocytosis in pathogenesis of Cryptococcus neorformans$328,500
R01 · FY2009 · AI · contact PI
Sphingolipid-mediated fungal pathogenesis$295,000
R01 · FY2009 · AI · contact PI
New methods for the early diagnosis of invasive fungal infections$221,250
R21 · FY2009 · AI · contact PI
Role of phagocytosis in pathogenesis of Cryptococcus neorformans$328,500
R01 · FY2008 · AI · contact PI
Sphingolipid-mediated fungal pathogenesis$237,657
R01 · FY2008 · AI · contact PI
New methods for the early diagnosis of invasive fungal infections$184,375
R21 · FY2008 · AI · contact PI
Sphingolipid-mediated fungal pathogenesis$242,261
R01 · FY2007 · AI · contact PI
SC COBRE: ROLE OF IPC1 IN REGULATION OF PHAGOCYTOSIS OF C NEOFORMANS$68,722
P20 · FY2007 · RR · contact PI
Sphingolipid-mediated fungal pathogenesis$249,496
R01 · FY2006 · AI · contact PI
SC COBRE: IPC1 IN REGULATION OF PHAGOCYTOSIS OF C NEOFORMANS$71,282
P20 · FY2006 · RR · contact PI
Sphingolipid-mediated fungal pathogenesis$255,500
R01 · FY2005 · AI
SC COBRE: IPC1 IN REGULATION OF PHAGOCYTOSIS OF C NEOFORMANS$140,859
P20 · FY2005 · RR
Sphingolipid-mediated fungal pathogenesis$280,500
R01 · FY2004 · AI
IPC1 IN REGULATION OF PHAGOCYTOSIS OF C. NEOFORMANS$193,488
P20 · FY2004 · RR
Role of Ipc1 in fungal pathogenesis$311,480
R21 · FY2003 · AI
IPC1 ROLE IN REGULATION OF PHAGOCYTOSIS OF C NEOFORMANS$0
P20 · FY2002 · RR